Pembrolizumab Registry for Outcomes and Treatment Evaluation in Cervical Cancer
Pembrolizumab Registry for Outcomes and Treatment Evaluation in Cervical Cancer
Recruiting · NCT07645625 · Registry updated 2026-06-29Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Pembrolizumab Registry for Outcomes and Treatment Evaluation in Cervical Cancer | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, Uterine Cervical Neoplasms, cervix disorder, female reproductive system disorder, female reproductive system neoplasm, neoplasm, uterine disorder | Recruiting | Phase 4 | 2026-06-29 | NCT07645625 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| University Medical Center Groningen | 213 |
11 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Amsterdam UMC | Amsterdam | Netherlands | 85 |
| Antoni van Leeuwenhoek Ziekenhuis | Amsterdam | Netherlands | 6 |
| Catharina Ziekenhuis | Eindhoven | Netherlands | 43 |
| Erasmus MC | Rotterdam | Netherlands | 57 |
| Isala Klinieken | Zwolle | Netherlands | 16 |
| LUMC | Leiden | Netherlands | 10 |
| Maastricht UMC | Maastricht | Netherlands | 23 |
| Medisch Spectrum Twente | Enschede | Netherlands | 36 |
| Radboud UMC | Nijmegen | Netherlands | 25 |
| UMC Utrecht | Utrecht | Netherlands | 42 |
| University Mecdical Center Groningen | Groningen | Netherlands | 1 |